该试剂盒包含以下主要成分：磷酸烯醇丙酮酸羧化酶，丙酮酸脱氢酶和稳定剂。
The kit comprises the following main components: phosphoenol pyruvate carboxylase, pyruvate dehydrogenase and a stabilizer.
有一些全酶是高度复杂的，如丙酮酸脱氢酶。
Some holoenzymes , such as pyruvate dehydrogenase , are highly complex , with several cofactors.
对目前几种丙酮酸脱氢酶测活的方法进行了比较研究。
Several current measuring methods for activity of pyruvate dehydrogenase are compared and studied.
它在中间代谢和能源生产中起作用，并可能与丙酮酸脱氢酶复合体紧密联系或相互作用。
It plays a role in intermediary metabolism and energy production and may tightly associate or interact with the pyruvate dehydrogenase complex.
因此预计通过遗传改造和发酵控制提高丙酮酸脱氢酶的活性可能会进一步提高虾青素的产率。
The production of astaxanthin can be improved from the genetic manipulation and fermentation control by enhance the activity of pyruvate dehydrogenase.
糖酵解产生的丙酮酸在正常条件下被丙酮酸脱氢酶(PDH)转化成乙酰辅酶a (1 - 3)。
Pyruvate generated from glycolysis is converted to acetyl-CoA by pyruvate dehydrogenase (PDH) under normoxia (1-3).
本发明的试剂盒主要成分包 括：缓冲液、还原型辅酶、草酰乙酸、乙酰辅酶A、磷酸烯醇式丙酮酸羧化酶、丙酮酸脱氢酶及稳定剂；
The kit comprises the following main components: buffer solution, reduced coenzyme, oxaloacetic acid, acetyl coenzyme A, phosphoenolpyruvate carboxylase, pyruvate dehydrogenase and a stabilizer.
低氧条件会直接诱导丙酮酸脱氢酶激酶1 (PDHK1)的表达，它的表达会抑制pdh的活性和TCA循环，从而抑制了随后的代谢通路(4)。
Hypoxia can directly induce pyruvate dehydrogenase kinase 1 (PDHK1) expression, which results in inactivation of PDH and the TCA cycle and subsequent suppression of metabolism (4).
本发明的试剂盒主要成分包括：缓冲液、辅酶、丙酮酸、氯化氨、丙酮酸氧化酶、甘氨酸氧化酶、丙氨酸脱氢酶及稳定剂；
The kit comprises the following main components: buffer solution, coenzyme, pyruvic acid, ammonia chloride, pyruvate oxidase, glycine oxidase, alanine dehydrogenase and a stabilizer.
本发明的试剂 盒主要成分包括：缓冲液、还原型辅酶、丙酮酸、腺苷三磷酸、丙酮酸氧化酶、 丙酮酸羧化酶、苹果酸脱氢酶及稳定剂；
The kit comprises the following main components: buffer solution, reduced coenzyme, pyruvic acid, adenosine triphosphate, pyruvate oxidase, pyruvate carboxylase, malic dehydrogenase and a stabilizer.
蓝光处理提高了幼苗丙酮酸激酶和苹果酸脱氢酶的活性。
Measurement of activities of key enzymes in respiratory pathways showed that the activities of pyruvate kinase and malate dehydrogenase were higher in blue light treatment.
本发明的试剂盒主要成分包 括：缓冲液、还原型辅酶、草酰乙酸、酮戊二酸、磷酸烯醇式丙酮酸羧化酶、 异柠檬酸脱氢酶及稳定剂；
The kit comprises the following main components: buffer solution, reduced coenzyme, oxaloacetic acid, ketoglutaric acid, phosphoenolpyruvate carboxykinase, isocitric dehydrogenase and a stabilizer.
本发明的试剂盒主要成分包 括：缓冲液、还原型辅酶、草酰乙酸、酮戊二酸、磷酸烯醇式丙酮酸羧化酶、 异柠檬酸脱氢酶及稳定剂；
The kit comprises the following main components: buffer solution, reduced coenzyme, oxaloacetic acid, ketoglutaric acid, phosphoenolpyruvate carboxykinase, isocitric dehydrogenase and a stabilizer.
应用推荐